These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute double blind trial of a new anti-anginal drug: molsidomine. Guerchicoff S; Vazquez A; Kunik H; Drajer S; Díaz F Eur J Clin Pharmacol; 1978 Jun; 13(4):247-50. PubMed ID: 352706 [TBL] [Abstract][Full Text] [Related]
3. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris. Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491 [No Abstract] [Full Text] [Related]
4. [Therapy of coronary heart disease with molsidomine]. Kaliman J; Uhlir H; Klicpera M MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846 [No Abstract] [Full Text] [Related]
5. [Action of molsidomine on haemodynamics at rest and on exercise in patients who have coronary heart disease (author's transl)]. Niehues B; Krimmel W; Hombach V; Tauchert M; Behrenbeck DW; Hilger HH Dtsch Med Wochenschr; 1978 May; 103(20):853-6. PubMed ID: 648365 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction. Aptecar M; Otero y Garzon CA; Vasquez A; Varini S; Collia L; Esteguy A; Caruso S Am Heart J; 1981 Apr; 101(4):369-73. PubMed ID: 6894215 [TBL] [Abstract][Full Text] [Related]
8. Effects of molsidomine on exercise tolerance in patients with coronary heart disease. Messin R; Demaret B; Denolin H Int J Cardiol; 1983 May; 3(2):137-44. PubMed ID: 6688064 [TBL] [Abstract][Full Text] [Related]
9. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease]. Fach WA; Becker HJ Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621 [TBL] [Abstract][Full Text] [Related]
10. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris]. Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947 [No Abstract] [Full Text] [Related]
11. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol. De Backer GG; Derese A Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735 [TBL] [Abstract][Full Text] [Related]
12. Clinical and hemodynamic effects of the new dilator drug molsidomine. Malcolm AD Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734 [TBL] [Abstract][Full Text] [Related]
13. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study. Baudry C Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013 [TBL] [Abstract][Full Text] [Related]
14. [The normalizing effect of ECG in exercise tolerance tests under molsidomine in different dosages (author's transl]. Jansen E; Klepzig H Med Klin; 1978 Jun; 73(26):983-6. PubMed ID: 672755 [TBL] [Abstract][Full Text] [Related]
15. Anti-ischemic effects of molsidomine in an experimental model of coronary artery stenosis. Nitz RE; Mogilev AM; Göbel H Adv Myocardiol; 1983; 4():595-604. PubMed ID: 6687948 [TBL] [Abstract][Full Text] [Related]
16. Molsidomine in the treatment of patients with angina pectoris. Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a new antihypertensive vasodilating agent PR--G 138 Cl. Vos J; Dorhout Mees EJ Br J Clin Pharmacol; 1979 Aug; 8(2):155-62. PubMed ID: 385024 [TBL] [Abstract][Full Text] [Related]